OSE Immunotherapeutics Presenting at the Annual International Conference BIO-EUROPE SPRING

Amsterdam, March 12-14, 2018. Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnémo: OSE), announces it will be featured as a presenting company at the 12 th Annual Conference BIO-EUROPE SPRING. The conference is being held on March 12-14, 2018 in Amsterdam.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.